Lincoln Pharmaceuticals Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 6/6
Lincoln Pharmaceuticals has a total shareholder equity of ₹5.9B and total debt of ₹10.7M, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are ₹7.0B and ₹1.1B respectively. Lincoln Pharmaceuticals's EBIT is ₹906.2M making its interest coverage ratio 60.9. It has cash and short-term investments of ₹1.5B.
Anahtar bilgiler
0.2%
Borç/özkaynak oranı
₹10.67m
Borç
| Faiz karşılama oranı | 60.9x |
| Nakit | ₹1.53b |
| Eşitlik | ₹5.93b |
| Toplam yükümlülükler | ₹1.07b |
| Toplam varlıklar | ₹7.00b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 531633's short term assets (₹4.5B) exceed its short term liabilities (₹922.8M).
Uzun Vadeli Yükümlülükler: 531633's short term assets (₹4.5B) exceed its long term liabilities (₹151.8M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 531633 has more cash than its total debt.
Borcun Azaltılması: 531633's debt to equity ratio has reduced from 11.8% to 0.2% over the past 5 years.
Borç Kapsamı: 531633's debt is well covered by operating cash flow (5925.9%).
Faiz Kapsamı: 531633's interest payments on its debt are well covered by EBIT (60.9x coverage).